Cargando…
Suppression of DLBCL Progression by the E3 Ligase Trim35 Is Mediated by CLOCK Degradation and NK Cell Infiltration
The majority of diffuse large B-cell lymphoma (DLBCL) patients develop relapsed or refractory disease after standard ruxolitinib, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy, which is partly related to a dysregulated tumor immune microenvironment. However, how th...
Autores principales: | Tan, Xiyan, Cao, Fuyang, Tang, Feiyu, Lu, Can, Yu, Qiaoyan, Feng, Songshan, Yang, Zhanghuan, Chen, Songming, He, Xiang, He, Jiang, Weng, Liang, Sun, Lunquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166485/ https://www.ncbi.nlm.nih.gov/pubmed/34124276 http://dx.doi.org/10.1155/2021/9995869 |
Ejemplares similares
-
Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2
por: Cao, Fuyang, et al.
Publicado: (2022) -
Dvl2 facilitates the coordination of NF‐κB and Wnt signaling to promote colitis‐associated colorectal progression
por: Tang, Feiyu, et al.
Publicado: (2021) -
Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation
por: Chen, Daici, et al.
Publicado: (2019) -
Origin and Diversification of TRIM Ubiquitin Ligases
por: Marín, Ignacio
Publicado: (2012) -
SLC3A2 promotes tumor‐associated macrophage polarization through metabolic reprogramming in lung cancer
por: Li, Zhuan, et al.
Publicado: (2023)